The bioavailability of HLA, representing the proportion of the compound that enters circulation after absorption, is notably low.
Animal studies indicate a bioavailability of less than 1%.† (2) To address this issue, LIPO HLA uses an advanced liposomal delivery system designed to improve the bioavailability, created for better absorption, and a slower release into the bloodstream.†